Stephanie Ascher | Stern Investor Relations |
Bryan Stuart | President and Chief Executive Officer |
Esther Rajavelu | CFO |
Paul Bruno | Senior Vice President, Corporate Development |
Dae Gon Ha | Stifel |
Judah Frommer | Credit Suisse |
Matt Biegler | Oppenheimer |
Joseph Schwartz | SVB Leerink |
Good morning, and welcome to Fulcrum Therapeutics Third Quarter 2022 Conference Call [Operator Instructions]. I would now like to turn the call over to Stephanie Ascher from Stern Investor Relations. Please proceed.
Thank you, Carolyn. Good morning, and welcome to the Fulcrum Therapeutics conference call.